Hyperkalemia and maintenance of renin–angiotensin system inhibitor therapy after initiating SGLT-2 or DPP-4 inhibitors
In patients with diabetes managed in routine clinical care, the use of SGLT-2i was associated with lower rates of hyperkalemia compared with DPP-4i. Possibly because of a relatively high rate of treatment discontinuations, this was not accompanied by higher persistence on RASi therapy.
Authors
- Anne‐Laure Faucon (ORCID: https://orcid.org/0000-0001-6716-1157)
- Edouard L. Fu (ORCID: https://orcid.org/0000-0002-9698-6825)
- Marie Evans (ORCID: https://orcid.org/0000-0001-8650-5795)
- Jung‐Im Shin (ORCID: https://orcid.org/0000-0003-0374-6927)
- Juan Jesús Carrero (ORCID: https://orcid.org/0000-0003-4763-2024)
- Alessandro Bosi (ORCID: https://orcid.org/0000-0002-2806-0393)
- Tao Huang (ORCID: https://orcid.org/0000-0002-0879-1850)
- Yang Xu (ORCID: https://orcid.org/0000-0002-1074-608X)
Institutions
- Karolinska University Hospital (SE)
- Johns Hopkins University (US)
- Inserm (FR)
- Peking University (CN)
- Université Paris-Saclay (FR)
- Leiden University Medical Center (NL)
- Karolinska Institutet (SE)
- Centre de recherche en Epidémiologie et Santé des Populations (FR)
Publication Details
- Journal
- Nephrology Dialysis Transplantation
- Published
- 2024-10-09
- DOI
- https://doi.org/10.1093/ndt/gfae227
- Citations
- 4
- Primary Topic
- Potassium and Related Disorders
- Type
- article
- Field-Weighted Citation Impact
- 1.68
Funders
- National Natural Science Foundation of China
- Nederlandse Organisatie voor Wetenschappelijk Onderzoek
- Vetenskapsrådet
- National Institutes of Health
- Young Scientists Fund